Showing results (131-140 of 281) with videos related to
Sort By:
Pageof 29
Journal of Bone and Mineral Metabolism|February 25, 2011
Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosisAlan Yancovitch, Dov Hershkovitz, Margareta Indelman, et al.The Journal of Investigative Dermatology|December 17, 2010
Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosisDov Hershkovitz, Yonit Gross, Sagi Nahum, et al.The American Journal of Dermatopathology|May 19, 2005
Absence of intraepidermal glycosyltransferase ppGalNac-T3 expression in familial tumoral calcinosisOrit Topaz, Reuven Bergman, Ulla Mandel, et al.The Journal of Investigative Dermatology|August 25, 2005
Identification of a novel locus associated with congenital recessive ichthyosis on 12p11.2-q13Mordechai Mizrachi-Koren, Dan Geiger, Margarita Indelman, et al.Journal of Medical Systems|December 31, 2022
Improving Hospital Outpatient Clinics Appointment Schedules by Prediction ModelsOrel Babayoff, Onn Shehory, Shamir Geller, et al.The Israel Medical Association Journal : IMAJ|February 18, 2019
Comparative Study of Frozen and Paraffin-Embedded Sections: Evaluation of Inflammatory DermatosesEran Ellenbogen, Shmuel Epshteyn, Shir Azrielant, et al.International Journal of Dermatology|June 30, 2005
A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgarisIrena Zagorodniuk, Sara Weltfriend, Lily Shtruminger, et al.Pediatric Dermatology|March 1, 2018
Risk of intraocular and other extracutaneous involvement in patients with cutaneous juvenile xanthogranulomaLiat Samuelov, Michael Kinori, Sarah L Chamlin, et al.Pediatric Blood & Cancer|July 31, 2010
Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantationRonit Elhasid, Norberto Krivoy, Jacob M Rowe, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2006
Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected childrenJacobo Abadi, Eli Sprecher, Michael G Rosenberg, et al.Pageof 29